Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.60 |
| ▸ | CNR2 | P34972 | 2/20 | 0.52 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.48 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.48 |
| ▸ | WNT3A | P56704 | 1/20 | 0.48 |
| ▸ | KDR | P35968 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | AHR | P35869 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29489280 | 0.86 | GPR84 (0.77) | GPR84CNR2PBRM1MEN1MAPT | |
| SCHEMBL8530849 | 0.86 | GPR84 (0.77) | GPR84CNR2PBRM1MEN1MAPT | |
| SCHEMBL6404030 | 0.84 | CNR2 (0.56) | GPR84CNR2PBRM1KDRNR4A2 | |
| SCHEMBL6402031 | 0.84 | SMN1; SMN2 (0.63) | GPR84CNR2NPC1RAB9AKDR | |
| SCHEMBL6429589 | 0.78 | GPR84 (0.52) | GPR84CNR2PBRM1CTNNB1WNT3A | |
| SCHEMBL22462631 | 0.78 | GPR84 (0.63) | GPR84PBRM1NPC1RAB9ACTNNB1 | |
| SCHEMBL2028344 | 0.78 | GPR84 (1.00) | GPR84PBRM1NPC1RAB9ACTNNB1 | |
| SCHEMBL6402673 | 0.76 | SMN1; SMN2 (0.63) | GPR84CNR2NPC1RAB9AKDR | |
| SCHEMBL2980233 | 0.76 | SMN1; SMN2 (0.71) | GPR84PBRM1NPC1RAB9ACASP3 | |
| SCHEMBL6238042 | 0.76 | LMNA (0.56) | GPR84RAB9AKDRMAPTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050009903-A1 | CB2-selective cannabinoid analogues | CLEMSON UNIVERSITY | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009903-A1 | CB2-selective cannabinoid analogues | CNR2, CNR1, GPR68 | GPR84 47/4885CNR2 1/4885PBRM1 590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.